Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms
- PMID: 19596934
Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms
Abstract
Background: Neuropathy is a common adverse effect of chemotherapy. The tricyclic antidepressant, amitriptyline, is a gold standard in the treatment of neuropathic pain. This double-blind, randomized placebo-controlled trial assessed the efficacy of amitriptyline to prevent chemotherapy-induced neuropathic symptoms.
Patients and methods: Patients without previous neuropathy, who started chemotherapy with vinca alcaloids, platina derivatives or taxanes, were randomized to receive amitriptyline (target dose, 100 mg daily) or placebo for the duration of their chemotherapy. Chemotherapy-induced neuropathic symptoms were evaluated with a patient diary and after every third chemotherapy cycle with clinical examination. The diary data were transformed to a neuropathy score. A total of 114 patients fulfilling the inclusion criteria were randomly assigned to the treatment or control arm.
Results: There was no difference in the appearance of chemotherapy-induced neuropathic symptoms between the groups. In general, the intensity of neuropathic symptoms was mild.
Conclusion: Amitriptyline does not prevent chemotherapy-induced neuropathy.
Similar articles
-
Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms.J Pain Symptom Manage. 2008 Jan;35(1):31-9. doi: 10.1016/j.jpainsymman.2007.02.043. Epub 2007 Nov 5. J Pain Symptom Manage. 2008. PMID: 17980550 Clinical Trial.
-
Topical amitriptyline versus lidocaine in the treatment of neuropathic pain.Clin J Pain. 2008 Jan;24(1):51-5. doi: 10.1097/AJP.0b013e318156db26. Clin J Pain. 2008. PMID: 18180637 Clinical Trial.
-
A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy.Clin Cancer Res. 2005 Mar 1;11(5):1890-8. doi: 10.1158/1078-0432.CCR-04-1655. Clin Cancer Res. 2005. PMID: 15756015 Clinical Trial.
-
Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.Ann Pharmacother. 2008 Oct;42(10):1481-5. doi: 10.1345/aph.1L179. Epub 2008 Aug 12. Ann Pharmacother. 2008. PMID: 18698011 Review.
-
Therapy of chemotherapy-induced peripheral neuropathy.Br J Haematol. 2009 Apr;145(1):3-14. doi: 10.1111/j.1365-2141.2008.07558.x. Epub 2009 Jan 16. Br J Haematol. 2009. PMID: 19170681 Review.
Cited by
-
Painful chemotherapy-induced peripheral neuropathy: lack of treatment efficacy or the wrong clinical trial methodology?Pain. 2017 Jan;158(1):30-33. doi: 10.1097/j.pain.0000000000000653. Pain. 2017. PMID: 27564867 Free PMC article. Review. No abstract available.
-
Pharmacological Modulation of the Mitochondrial Electron Transport Chain in Paclitaxel-Induced Painful Peripheral Neuropathy.J Pain. 2015 Oct;16(10):981-94. doi: 10.1016/j.jpain.2015.06.008. Epub 2015 Jul 2. J Pain. 2015. PMID: 26142652 Free PMC article. Clinical Trial.
-
Efficacy of Auricular Acupuncture in Chemotherapy-Induced Peripheral Neuropathy: A Case Series of 73 Cases.Med Acupunct. 2021 Jun 1;33(3):212-218. doi: 10.1089/acu.2020.1506. Epub 2021 Jun 16. Med Acupunct. 2021. PMID: 35003493 Free PMC article.
-
Amitriptyline's anticholinergic adverse drug reactions-A systematic multiple-indication review and meta-analysis.PLoS One. 2023 Apr 5;18(4):e0284168. doi: 10.1371/journal.pone.0284168. eCollection 2023. PLoS One. 2023. PMID: 37018325 Free PMC article.
-
Evidence-Based Treatment of Pain in Chemotherapy-Induced Peripheral Neuropathy.Curr Pain Headache Rep. 2023 May;27(5):99-116. doi: 10.1007/s11916-023-01107-4. Epub 2023 Apr 14. Curr Pain Headache Rep. 2023. PMID: 37058254
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
